The following information is missing from the Funding section: A.D. was supported by an American Cancer Society (ACS) New faculty Career Development Grant, and by a “Walter B. Frommeyer Jr. Fellowship in investigative medicine."
Reference
- 1.Minagawa K, Jamil MO, AL-Obaidi M, Pereboeva L, Salzman D, Erba HP, et al. (2016) In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS ONE 11(12): e0166891 doi:10.1371/journal.pone.0166891 [DOI] [PMC free article] [PubMed] [Google Scholar]